Morgan Stanley’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-125,832
| Closed | -$580K | – | 6883 |
|
|
2019
Q1 | $580K | Buy |
125,832
+68,188
| +118% | +$323K | ﹤0.01% | 4463 |
|
|
2018
Q4 | $202K | Sell |
57,644
-10,600
| -16% | -$73.7K | ﹤0.01% | 5283 |
|
|
2018
Q3 | $688K | Sell |
68,244
-14,752
| -18% | -$118K | ﹤0.01% | 4795 |
|
|
2018
Q2 | $601K | Buy |
82,996
+7,590
| +10% | +$52.9K | ﹤0.01% | 4971 |
|
|
2018
Q1 | $455K | Sell |
75,406
-16,844
| -18% | -$139K | ﹤0.01% | 5059 |
|
|
2017
Q4 | $888K | Sell |
92,250
-88,657
| -49% | -$580K | ﹤0.01% | 4618 |
|
|
2017
Q3 | $1.61M | Buy |
180,907
+44,115
| +32% | +$455K | ﹤0.01% | 4072 |
|
|
2017
Q2 | $1.73M | Buy |
136,792
+2,416
| +2% | +$28.6K | ﹤0.01% | 3930 |
|
|
2017
Q1 | $1.41M | Sell |
134,376
-8,598
| -6% | -$91.6K | ﹤0.01% | 4114 |
|
|
2016
Q4 | $1.31M | Sell |
142,974
-13,918
| -9% | -$157K | ﹤0.01% | 4257 |
|
|
2016
Q3 | $1.85M | Buy |
156,892
+36,156
| +30% | +$550K | ﹤0.01% | 3555 |
|
|
2016
Q2 | $1.56M | Sell |
120,736
-64,592
| -35% | -$941K | ﹤0.01% | 3628 |
|
|
2016
Q1 | $2.96M | Buy |
185,328
+41,942
| +29% | +$797K | ﹤0.01% | 3001 |
|
|
2015
Q4 | $4.11M | Sell |
143,386
-40,395
| -22% | -$1.12M | ﹤0.01% | 2865 |
|
|
2015
Q3 | $5.23M | Buy |
183,781
+128,871
| +235% | +$4.74M | ﹤0.01% | 2621 |
|
|
2015
Q2 | $1.97M | Sell |
54,910
-106,138
| -66% | -$3.31M | ﹤0.01% | 3637 |
|
|
2015
Q1 | $4.68M | Sell |
161,048
-392,100
| -71% | -$10.4M | ﹤0.01% | 2817 |
|
|
2014
Q4 | $11.7M | Buy |
553,148
+458,228
| +483% | +$9.06M | ﹤0.01% | 1917 |
|
|
2014
Q3 | $1.84M | Sell |
94,920
-224,000
| -70% | -$3.52M | ﹤0.01% | 3513 |
|
|
2014
Q2 | $4.98M | Sell |
318,920
-96,124
| -23% | -$1.55M | ﹤0.01% | 2672 |
|
|
2014
Q1 | $8.6M | Sell |
415,044
-193,380
| -32% | -$3.84M | ﹤0.01% | 2076 |
|
|
2013
Q4 | $7.85M | Buy |
608,424
+170,811
| +39% | +$2.37M | ﹤0.01% | 2146 |
|
|
2013
Q3 | $5.1M | Buy |
437,613
+389,436
| +808% | +$3.2M | ﹤0.01% | 2405 |
|
|
2013
Q2 | $222K | Buy |
+48,177
| New | +$177K | ﹤0.01% | 4784 |
|
Other funds holding INSY
WS
Morgan Stanley's INSY Position: Q2 2019 in Review
Morgan Stanley sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 125,832 shares — an estimated $580K sold.
Morgan Stanley first reported a position in INSY in Q2 2013 and held it in 24 quarters. The position peaked at $11.7M in Q4 2014. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.
- Morgan Stanley reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- Morgan Stanley sold 125,832 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $580K.
- Morgan Stanley first reported a position in Insys Therapeutics, Inc. in Q2 2013 and held it in 24 quarters.
- Morgan Stanley's Insys Therapeutics, Inc. position peaked at $11.7M in Q4 2014.
- 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.
Based on Morgan Stanley's 13F filing for Q2 2019, filed 14 Aug 2019.